Aspire Biopharma Holdings, Inc.
Price Action
Technical Summary
WEAKENINGAspire Biopharma Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings growth of 87% provides fundamental context to the price action. However, price is extended 20% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.02 | +5.77% | ABOVE |
| 50 SMA | $0.02 | +20.22% | ABOVE |
| 100 SMA | $0.02 | +16.40% | ABOVE |
| 150 SMA | $0.02 | +5.26% | ABOVE |
| 200 SMA | $0.03 | -14.40% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ASBPW in an uptrend right now?
ASBPW has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ASBPW overbought or oversold?
ASBPW's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.
Is ASBPW outperforming the market?
ASBPW has a Relative Strength (RS) Rating of 90 out of 99. Yes, ASBPW is a market leader, outperforming 90% of all stocks over the past 12 months.
Where is ASBPW in its 52-week range?
ASBPW is trading at $0.02, which is 24% of its 52-week high ($0.09) and 15% above its 52-week low ($0.01).
How volatile is ASBPW?
ASBPW has a Beta of 1.24 and 52-week volatility of 281%. It's more volatile than the S&P 500 - expect bigger swings.